Production (Stage)
Organon & Co.
OGN
$9.56
$0.374.03%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.96% | 0.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.96% | 0.63% | |||
| Cost of Revenue | -3.45% | 5.61% | |||
| Gross Profit | -6.14% | -2.93% | |||
| SG&A Expenses | -10.26% | 10.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.19% | 8.56% | |||
| Operating Income | 9.06% | -23.59% | |||
| Income Before Tax | -21.71% | -37.68% | |||
| Income Tax Expenses | -30.00% | 113.16% | |||
| Earnings from Continuing Operations | -20.18% | -69.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -20.18% | -69.64% | |||
| EBIT | 9.06% | -23.59% | |||
| EBITDA | 9.07% | -18.30% | |||
| EPS Basic | -20.24% | -69.66% | |||
| Normalized Basic EPS | 37.74% | -42.67% | |||
| EPS Diluted | -19.83% | -70.17% | |||
| Normalized Diluted EPS | 37.26% | -42.67% | |||
| Average Basic Shares Outstanding | 0.07% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.43% | 0.05% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.20% | 2.29% | |||